Definitive Contract 75D30122C15711
Award Date
9/30/22
Potential Completion Date
9/30/24
Potential Value
$541K
Federal Agency
CDC Pittsburgh
Awardee
Evolva AG
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Switzerland
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Cost Plus Fixed Fee definitive contract to Evolva Inc., a foreign-owned for-profit organization, for the development of NOOTKATONE, a Novel Toxicant and Repellent for Arthropod-Borne Virus Vectors (NTRAVV). The contract, which does not have a set-aside designation, has a potential value of $9,052,602.60 and a completion date of December 1, 2020. The place of performance is...
This federal contract award, ID 75D30124C19005, was issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Danstar Ferment AG, a for-profit organization based in Zug, Switzerland. The $562,070.00 Firm Fixed Price contract is for the delivery of NOOKATONE BASED PRODUCTS_TICK REPELENT and has a final completion date of February 28, 2026. This is a definitive contract and does not utilize any set-aside designations. The contract was awarded on September 1, 2024 and the...
This federal contract award was made by the National Cancer Institute (NCI) to Evotec US Inc., a foreign-owned, for-profit organization that provides chemical procurement, analysis, sample preparation, and management services. The contract, valued at $5,843.89, is a Delivery Order under the NCI's Chemical Biology Consortium Screening Libraries Center major program. The contract does not utilize any set-aside designations. Evotec US Inc. is performing the work as the prime contractor without...
This federal contract award to Evotec US Inc., a foreign-owned for-profit organization, was made by the National Cancer Institute (NCI) to establish a small molecule chemical repository for the NCI Chemical Biology Consortium. The $5,837,230.82 cost-plus-fixed-fee definitive contract has a period of performance through September 29, 2015 and does not utilize any set-aside designations. Evotec specializes in chemical procurement, analysis, sample preparation, and management services, and has a...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $236,150 purchase order to Life Technologies Corporation for technical advisory cards focusing on vector-borne human febunaviruses. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division. The contract has a period of performance from September 10, 2020 through December 7, 2020 and utilizes a firm fixed price payment structure. The work will...
This is a $593,457.00 firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Schweizerisches Tropen- UND Public Health-Institut, Swiss TPH Division, a non-profit organization based in Switzerland. The contract is for critical functions related to brucellosis prevention and control activities. This award does not have a set-aside designation. Schweizerisches Tropen- UND Public Health-Institut, Swiss TPH Division has received multiple federal...
Evotec US Inc., a foreign-owned for-profit organization, was awarded a firm-fixed-price delivery order by the Environmental Protection Agency's Office of Research and Development under contract 68HE0D18D0001 to provide chemical procurement, analysis, sample preparation, and management services. The current order, valued at $224,810.56, has a completion date of March 21, 2022. Evotec has received several similar delivery orders under this contract since 2019, ranging from approximately $20,000 to...
This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
This is a $834,062.90 definitive, firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to the Swiss Federal Institute of Technology (ETH Zurich) for the "Evaluation of Emerging Infections During Pregnancy and Their Prevention". The contract has a performance period through September 28, 2025 and does not have a set-aside designation. ETH Zurich, a leading international university for technology and the natural sciences, will serve as the prime...
This is a $4,937,118.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Institut De Formulation DES Vaccins (Ch) SA, operating as Vaccine Formulation Institute (Ch) LTD, a for-profit limited liability company based in Switzerland. The contract is for the advanced development of a liposome-based saponin-containing adjuvant for use in pan-sarbecovirus vaccines. This...